Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Lamsfus

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Pathogens (Basel, Switzerland)|October 23, 2021
Immunosuppression in Malaria: Do <i>Plasmodium falciparum</i> Parasites Hijack the Host?Carlos Lamsfus Calle, Benjamin Mordmüller, Anurag Singh
Sensors (Basel, Switzerland)|May 14, 2013
A methodology and a web platform for the collaborative development of context-aware systemsDavid Martín, Diego López-de-Ipiña, Aurkene Alzua-Sorzabal, et al.
Sensors (Basel, Switzerland)|July 11, 2012
Context-based tourism information filtering with a semantic rule engineCarlos Lamsfus, David Martin, Aurkene Alzua-Sorzabal, et al.
Sensors (Basel, Switzerland)|June 26, 2013
Context management platform for tourism applicationsDavid Buján, David Martín, Ortzi Torices, et al.
Frontiers in Immunology|April 5, 2021
Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria InfectionCarlos Lamsfus Calle, Rolf Fendel, Anurag Singh, et al.
Microbiology Spectrum|August 28, 2024
Slow clearance of histidine-rich protein-2 in Gabonese with uncomplicated malariaCarlos Lamsfus Calle, Frieder Schaumburg, Thorsten Rieck, et al.
Scientific Reports|July 15, 2021
Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patientsThirumalaisamy P Velavan, Salih Kuk, Le Thi Kieu Linh, et al.
Vaccines|November 26, 2024
First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine BoosterMeral Esen, Johanna Fischer-Herr, Julian Justin Gabor, et al.
The Lancet. Infectious Diseases|April 2, 2017
DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infectionMihály Sulyok, Thomas Rückle, Alexandra Roth, et al.
Plos Neglected Tropical Diseases|May 21, 2024
Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic settingGerrit Burger, Rafiou Adamou, Ruth Kreuzmair, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pathogens (Basel, Switzerland)|October 23, 2021
Immunosuppression in Malaria: Do <i>Plasmodium falciparum</i> Parasites Hijack the Host?Carlos Lamsfus Calle, Benjamin Mordmüller, Anurag Singh
Sensors (Basel, Switzerland)|May 14, 2013
A methodology and a web platform for the collaborative development of context-aware systemsDavid Martín, Diego López-de-Ipiña, Aurkene Alzua-Sorzabal, et al.
Sensors (Basel, Switzerland)|July 11, 2012
Context-based tourism information filtering with a semantic rule engineCarlos Lamsfus, David Martin, Aurkene Alzua-Sorzabal, et al.
Sensors (Basel, Switzerland)|June 26, 2013
Context management platform for tourism applicationsDavid Buján, David Martín, Ortzi Torices, et al.
Frontiers in Immunology|April 5, 2021
Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria InfectionCarlos Lamsfus Calle, Rolf Fendel, Anurag Singh, et al.
Microbiology Spectrum|August 28, 2024
Slow clearance of histidine-rich protein-2 in Gabonese with uncomplicated malariaCarlos Lamsfus Calle, Frieder Schaumburg, Thorsten Rieck, et al.
Scientific Reports|July 15, 2021
Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patientsThirumalaisamy P Velavan, Salih Kuk, Le Thi Kieu Linh, et al.
Vaccines|November 26, 2024
First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine BoosterMeral Esen, Johanna Fischer-Herr, Julian Justin Gabor, et al.
The Lancet. Infectious Diseases|April 2, 2017
DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infectionMihály Sulyok, Thomas Rückle, Alexandra Roth, et al.
Plos Neglected Tropical Diseases|May 21, 2024
Eosinophils, basophils and myeloid-derived suppressor cells in chronic Loa loa infection and its treatment in an endemic settingGerrit Burger, Rafiou Adamou, Ruth Kreuzmair, et al.
Pageof 2